Tetraphase Pharmaceuticals, Inc. Blog | Talkmarkets | Page 1
No data available
No data available
Latest Posts
1 to 15 of 15 Posts
Stock Charts To Watch - Wednesday, Jan. 22
Video By: Harry Boxer Wednesday, January 22, 2020 10:14 PM EDT
ACM Research, Inc. exploded on Wednesday, jumping 5.84, or 14%, to 48.51, after reaching a session and 52-week high of 51.20, on 2.8 million shares.
In this video: AGTC, ACMR, CCC, SEAC, TTPH, NTNX, SPCE
Watch
E US Stock Market Weekly Update October 28-November 1, 2019
Article By: Stavros Georgiadis Sunday, November 3, 2019 7:00 AM EDT
U.S. stocks closed to fresh record highs after the October jobs report release.
In this article: NC, CRUS, RAIL, TTPH, FOMX, BBIO
Read
Week In Review: Agilent Pays $250 Million To Acquire ACEA And Its Cell Therapy Analyzer
Article By: ChinaBio® Today Saturday, September 29, 2018 4:11 PM EDT
ACEA Biosciences, a San Diego company with R&D and manufacturing facilities in Hangzhzou, will be acquired by Agilent for $250 million in cash. ACEA developed the xCELLigence® cell therapy analysis device used by academic and biopharma researchers.
In this article: A, VSTM, NVS, CBMG, TTPH
Read
Week In Review: Mevion Medical Of Boston Closes $150 Million Financing From China Investors
Article By: ChinaBio® Today Saturday, June 16, 2018 4:07 PM EDT
Mevion Medical Systems, a Boston area maker of proton therapy machines, closed a $150 million financing led by YuanMing Capital with participation by other China-based private equity investors.
In this article: APTO, BMY, TTPH
Read
Week In Review: Taiwan Liposome Files For $50 Million Secondary IPO In The US
Article By: ChinaBio® Today Saturday, February 24, 2018 5:33 PM EDT
Taiwan Liposome (TW: 4152), a company developing extended-release delivery of known drugs, filed for a $50 million IPO on the NASDAQ exchange (see story). The company is listed in Taiwan, where it has a market capitalization of $198 million.
In this article: TTPH
Read
E Shares Of Tetraphase Tumble 26% Lower After FDA Guidance
Article By: Terry Chrisomalis Thursday, May 12, 2016 7:07 PM EDT
FDA requires another trial, setting back any ability to apply for NDA.
In this article: TTPH
Read
Buy These 2 Small Biotechs With Huge Upside
Article By: Bret Jensen Sunday, September 13, 2015 1:54 PM EDT
It's important to have 50% to 75% of one’s biotech portfolio in the large cap growth stocks but it also pays to take small stakes in a myriad of speculative but promising small cap companies in this lucrative space.
In this article: LXRX, AMGN, CELG, GILD, REGN, TTPH
Read
E Tetraphase Misses Primary Endpoint For Phase 3 Trial
Article By: Terry Chrisomalis Tuesday, September 8, 2015 5:54 PM EDT
Shares of Tetraphase are down 80% in after-hours trading after eravacycline missed the primary endpoint for one of its phase 3 trials.
In this article: TTPH
Read
Upcoming Events In Biotechnology: OVAS, ICPT, TTPH, RCPT
Article By: TipRanks Tuesday, April 7, 2015 9:38 AM EDT
On April 6, analysts at Wedbush led by Liana Moussatos highlighted upcoming events in the biotech sector. Here is what to watch for:
In this article: OVAS, TTPH, ICPT, RCPT
Read
2 $10 Biotech Stocks To Buy Before The End Of The Week
Article By: Bret Jensen Wednesday, January 7, 2015 5:12 AM EDT
Nothing can provide the returns of investing in a small cap biotech or biopharma company. Gilead Sciences is now a biotech juggernaut whose market capitalization is north of $150 billion and has returned over 14,000% in 20 years
In this article: CNAT, GILD, HALO, PFE, JNJ, TTPH
Read
4 Biotech Stocks That Doubled In 2014
Article By: Zacks Investment Research Friday, December 26, 2014 11:16 AM EDT
It has been an eventful year for the biotech sector with mergers and acquisitions (M&As) and deals showing no signs of slowing down.
In this article: ACHN, AGIO, PTCT, TTPH
Read
After Merck-Cubist Merger, Is Tetraphase Pharmaceuticals In In The Pipeline To Be Acquired?
Article By: BioMedReports Monday, December 15, 2014 2:50 PM EDT
Tetraphase Pharmaceuticals Inc may put itself up for sale.
In this article: TTPH
Read
Cempra Poised To Join Antibacterial Drug Acquisition Rumor Buzz With Upcoming Data Release
Article By: Scott Matusow Monday, November 24, 2014 12:28 PM EDT
Cempra Pharmaceuticals expects top-line data release for community acquired bacterial pneumonia by the end of Q1'15. With the very recent Tetraphase acquisition rumor buzz, Cempra is certain to join the acquisition buzz fray if its data release proves positive.
In this article: CBST, CEMP, TTPH
Read
Thinking Differently About Ebola Virus Disease: WBB Securities' Steve Brozak
Article By: The Life Sciences Report Friday, November 14, 2014 6:49 AM EDT
Mdtech analyst that has allowed the WBB Securities cofounder to develop a reasoned perspective on how West Africa's Ebola epidemic might be humanely halted. Brozak also mentions small-cap names that could considerably enhance investors' portfolios.
In this article: GSK, JNJ, NBS, BCRX, OMER, TKMR, CEMP, SRPT, CMRX, TTPH, NAVB
Read
Active Stocks: TTPH, RPRX, HZNP, THRX, MYGN
Article By: BioMedReports Friday, October 17, 2014 5:12 PM EDT
U.S. stocks rallied Friday, extending a string of sharp moves, amid upbeat economic news from the U.S. and rising hopes for more stimulus from global central banks.
In this article: RPRX, THRX, HZNP, MYGN, TTPH
Read
1 to 15 of 15 Posts